- Filed
- Apr 21, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 14, 2026 | 72.8M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 73.4M sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 77.8M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $414.8M |
| Stock Repurchased restated | Q1 2026 · Mar 31, 2025 | $213.1M |
| Dividends Paid | Q1 2026 · Mar 31, 2026 | $150.5M |
| Dividends Paid restated | Q1 2026 · Mar 31, 2025 | $143.8M |
| Capex | Q1 2026 · Mar 31, 2026 | $2.8M |
| Capex restated | Q1 2026 · Mar 31, 2025 | $11.6M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $306.8M |
| Operating Cash Flow restated | Q1 2026 · Mar 31, 2025 | $301.7M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $6.4B |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $6.2B |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $385.3M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $515.3M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | −$2.77B |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | −$2.65B |
| Stockholders Equity restated | Q1 2026 · Mar 31, 2025 | −$958.6M |
| Stockholders Equity restated | Q1 2026 · Dec 31, 2024 | −$940M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $1.61B |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $1.83B |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $8.32B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $8.36B |
| Current Assets | Q1 2026 · Mar 31, 2026 | $1.39B |
| Current Assets | Q1 2026 · Dec 31, 2025 | $1.64B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $5.55B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $5.7B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $5.53 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $3.71 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $5.54 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $3.72 |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $49.6M |
| Rd Expense restated | Q1 2026 · Mar 31, 2025 | $47.6M |
| Net Income | Q1 2026 · Mar 31, 2026 | $406M |
| Net Income | Q1 2026 · Mar 31, 2025 | $288.6M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $456.9M |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | $377M |
| Revenue | Q1 2026 · Mar 31, 2026 | $850.8M |
| Revenue restated | Q1 2026 · Mar 31, 2025 | $745.8M |